- Home
- NMRA vs GHI Comparison
NMRA vs GHI Comparison
Compare NMRA & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- GHI
- Stock Information
- Founded
- NMRA 2019
- GHI 1998
- Country
- NMRA United States
- GHI United States
- Employees
- NMRA N/A
- GHI 5
- Industry
- NMRA
- GHI Finance: Consumer Services
- Sector
- NMRA
- GHI Finance
- Exchange
- NMRA Nasdaq
- GHI Nasdaq
- Market Cap
- NMRA 268.5M
- GHI 254.1M
- IPO Year
- NMRA 2023
- GHI N/A
- Fundamental
- Price
- NMRA $1.62
- GHI $10.83
- Analyst Decision
- NMRA Buy
- GHI Strong Buy
- Analyst Count
- NMRA 8
- GHI 4
- Target Price
- NMRA $7.14
- GHI $14.88
- AVG Volume (30 Days)
- NMRA 931.0K
- GHI 64.6K
- Earning Date
- NMRA 08-06-2025
- GHI 08-07-2025
- Dividend Yield
- NMRA N/A
- GHI 13.67%
- EPS Growth
- NMRA N/A
- GHI N/A
- EPS
- NMRA N/A
- GHI N/A
- Revenue
- NMRA N/A
- GHI $27,326,828.00
- Revenue This Year
- NMRA N/A
- GHI $228.92
- Revenue Next Year
- NMRA N/A
- GHI $4.27
- P/E Ratio
- NMRA N/A
- GHI N/A
- Revenue Growth
- NMRA N/A
- GHI N/A
- 52 Week Low
- NMRA $0.61
- GHI $10.12
- 52 Week High
- NMRA $17.19
- GHI $14.51
- Technical
- Relative Strength Index (RSI)
- NMRA 51.72
- GHI 49.14
- Support Level
- NMRA $1.56
- GHI $10.45
- Resistance Level
- NMRA $1.78
- GHI $11.12
- Average True Range (ATR)
- NMRA 0.12
- GHI 0.27
- MACD
- NMRA -0.03
- GHI 0.07
- Stochastic Oscillator
- NMRA 58.97
- GHI 70.10
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.